Neuronal and mitochondrial phenotypes in iPSC-derived bipolar disorder models with and without a family history of mitochondrial disease
Neurobiology of Disease · 2026-11 · 107673
DOI: 10.1016/j.nbd.2026.107673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2026-11. Verfasst von Dana El Soufi El Sabbagh und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Toronto, 777 Bay Street, Toronto, Ontario M5G 2C8, Canada; Mitochondrial Innovation Initiati…. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council, Brain & Behavior Research Foundation, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Psychiatric disorders frequently accompany primary mitochondrial diseases (PMDs), suggesting shared biological pathways between mitochondrial function and psychiatric vulnerability. In this exploratory study, we investigated whether bipolar disorder (BD) occurring in the context of a family history of primary mitochondrial disease is associated with differences in neuronal and mitochondrial phenotypes. We generated induced pluripotent stem cells (iPSCs), neural progenitor cells (NPCs), and cortical neurons (CNs) from three non-psychiatric controls, three individuals with BD without a family history of mitochondrial disease, and three individuals with BD who did not themselves have mitochondrial disease but had relatives with clinically diagnosed mitochondrial (BD-FHMD). Our primary endpoints were distinguished network activity and cytosolic and mitochondrial Ca2+ dynamics, complemented by measurements of mitochondrial and cellular function and metabolomic profiles across differentiation. Across neurodifferentiation, we assessed neuronal network activity, calcium dynamics, mitochondrial and cellular health, and metabolomic signatures. BD neurons exhibited sustained hyperexcitability with increased firing and burst activity. In contrast, BD-FHMD neurons showed lower network activity with enhanced cytosolic calcium responses and prolonged mitochondrial calcium transients. BD-FHMD also exhibited stage-dependent mitochondrial alterations, while BD and BD-FHMD showed distinct developmental metabolic signatures. Together, these findings identify two distinct mitochondrial-associated phenotypes within BD. BD is characterized by a hyperexcitable neuronal phenotype associated with altered developmental metabolic programming, whereas BD-FHMD exhibits calcium dysregulation and altered mitochondrial developmental trajectories consistent with increased bioenergetic vulnerability. These findings suggest that BD occurring in the context of a family history of primary mitochondrial disease may be characterized by a distinct pattern of neuronal and mitochondrial dysfunction. Replication in larger, independently characterized cohorts will be important to determine whether this family-history-defined phenotype can contribute to biologically informed subtyping and therapeutic approaches in BD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, University of Toronto, 777 Bay Street, Toronto, Ontario M5G 2C8, Canada; Mitochondrial Innovation Initiative (MITO2i), University of Toronto, 777 Bay Street, Toronto, Ontario M…
- Krembil Brain Institute, Toronto Western Hospital, University Health Network, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada; Department of Physiology, Temerty Faculty of Medicine, University of Toronto, 1 King's…
- Department of Pharmacology and Toxicology, University of Toronto, 777 Bay Street, Toronto, Ontario M5G 2C8, Canada.
- Deakin University, IMPACT - Institute for Mental and Physical Health and Clinical Translation, School of Medicine, 75 Pigdons Road, Waurn Ponds, Victoria 3216, Australia.
- Donald K. Johnson Eye Institute, Krembil Research Institute, University Health Network, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada; Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medic…
- Department of Pharmacology and Toxicology, University of Toronto, 777 Bay Street, Toronto, Ontario M5G 2C8, Canada; Centre for Addiction and Mental Health, 1001 Queen Street West, Toronto, Ontario M6J 1H4, Canada; Depar…
Förderung
- National Health and Medical Research Council
- Brain & Behavior Research Foundation
- Canadian Institutes of Health Research
Zitieren
APA
El Sabbagh, D. E. S., Choi, J., Balachandar, L., Haydarian, E., Demyati, J., Mazhar, Z., Duong, A., Bortolasci, C. C., Irwin, C., Singh, K. K., Berk, M., Walder, K., Young, L. T., Carlen, P. L., & Andreazza, A. C. (2026). Neuronal and mitochondrial phenotypes in iPSC-derived bipolar disorder models with and without a family history of mitochondrial disease. Neurobiology of Disease, 107673. https://doi.org/10.1016/j.nbd.2026.107673
Vancouver
El Sabbagh DES, Choi J, Balachandar L, Haydarian E, Demyati J, Mazhar Z, et al. Neuronal and mitochondrial phenotypes in iPSC-derived bipolar disorder models with and without a family history of mitochondrial disease. Neurobiology of Disease. 2026:107673. doi:10.1016/j.nbd.2026.107673
BibTeX
@article{ElSabbagh2026,
author = {El Sabbagh, Dana El Soufi and Choi, Jaehyoung and Balachandar, Lakshmini and Haydarian, Eileen and Demyati, Jude and Mazhar, Zaara and Duong, Angela and Bortolasci, Chiara Cristina and Irwin, Courtney and Singh, Karun K and Berk, Michael and Walder, Ken and Young, L Trevor and Carlen, Peter L and Andreazza, Ana Cristina},
title = {Neuronal and mitochondrial phenotypes in iPSC-derived bipolar disorder models with and without a family history of mitochondrial disease},
journal = {Neurobiology of Disease},
year = {2026},
pages = {107673},
doi = {10.1016/j.nbd.2026.107673}
}
EUVIMED